CLINICAL EVIDENCE ClosureFast Procedure

Building long-term evidence with high clinical standards

GO GAP-FREE FOR PATENTED PERFORMANCE

ClosureFast Procedure Before and After

Individual results may vary.

Images courtesy of Jonathan Calure, M.D. of Maryland Vein Professionals.

The ClosureFast procedure, with its patented overlap design, is the only RFA procedure with published long-term clinical data demonstrating safety and efficacy, with a 91.9% closure rate at 5 years.1,2

  • 250+ published clinical studies and articles3
  • Over 2 million patients have been treated with the ClosureFast procedure in over 100 countries around the world.4

5-year study results

ClosureFast 5-Year Outcomes
1

Proebstle, T.M., Alm, B.J., Gockeritz, O., et al. Five-year Results from the Prospective European Multicentre Cohort Study on Radiofrequency Segmental Thermal Ablation for Incompetent Great Saphenous Veins. BR J Surg. 2015;102:212-8.

2

ClosureFast and ClosureFast RFS Patents. https://www.medtronic.com/content/dam/medtronic-com/global/Corporate/meaningful-innovation/documents/CVG-Patent-Marking.pdf.pdf

3

Medtronic ClosureFast Procedure Publications. Medtronic data on file. 2019

4

ClosureFast Procedures. Medtronic data on file. 2019.

5

Morrison, N. VeClose Extension Study Five-year Results. Presented at Charing Cross, April 16, 2019; London, UK.